Key result
Cardiac aging enriches profibrotic TLF+CD209hi resident macrophages, driving fibroblast activation via EGFR and PDGFRa signaling.
Why the study?
Cardiac aging features diastolic dysfunction, interstitial fibrosis, and higher HFpEF risk, yet how macrophage heterogeneity, senescence, and intercellular signaling converge during physiological aging remains unclear.
Does physiological aging drive macrophage senescence and an aging-enriched TLF+CD209hi resident macrophage state that promotes cardiac fibroblast activation and myocardial fibrosis?
Does physiological aging drive macrophage senescence and an aging-enriched TLF+CD209hi resident macrophage state that promotes cardiac fibroblast activation and myocardial fibrosis?
Answers are grounded in this paper and cite their sources.
This study identifies an aging-enriched TLF+CD209hi cardiac resident macrophage subset and nominates HB-EGF/AREG-EGFR and IL-10-associated PDGF-A/PDGFRα signaling as candidate profibrotic circuits driving age-related myocardial fibrosis and diastolic dysfunction.
Cardiac aging is characterized by diastolic dysfunction, interstitial fibrosis, and increased risk of heart failure with preserved ejection fraction (HFpEF), yet how macrophage heterogeneity, senescence, and intercellular signaling converge during physiological aging remains unclear. We integrated echocardiography, histology, immunostaining, flow cytometry, and single-cell RNA sequencing of sorted CD45⁺ cells from young and aged C57BL/6J mouse hearts, alongside human cardiac immunostaining. Aged mice developed diastolic dysfunction, ventricular remodeling, cardiomyocyte hypertrophy, and interstitial fibrosis, accompanied by immune-cell expansion. Exploratory single-cell transcriptomic analysis of pooled young and aged cardiac immune-cell libraries highlighted macrophages as a prominently remodeled immune population and identified an aging-enriched TLF⁺ (expressing Timd4 and/or Lyve1 and/or Folr2) CD209hi state within the tissue-resident macrophage compartment. Aged macrophages displayed increased senescence-associated secretory phenotype-related transcriptional activity, pro-inflammatory and profibrotic programs, and subset-specific metabolic and regulatory transcriptional programs. MHC-II⁺ macrophages showed a glycolytic inflammatory state, whereas TLF⁺CD209hi macrophages exhibited profibrotic programs enriched for extracellular matrix remodeling, epidermal growth factor family signaling, and IL-10-associated communication. Cell-cell communication and flow cytometry nominated HB-EGF/AREG-EGFR and IL-10-associated PDGF-A/PDGFRα signaling as candidate macrophage-fibroblast profibrotic circuits. In primary adult mouse cardiac fibroblasts, HB-EGF and PDGF-AA increased selected fibrosis-associated markers and EGFR/ERK or PDGFRα/ERK phosphorylation, respectively; pharmacological inhibition attenuated some responses. These findings link macrophage senescence-associated remodeling and an aging-enriched TLF⁺CD209hi state to fibrosis-associated features and nominate EGF-family ligands and IL-10-associated PDGF-A/PDGFRα signaling as candidate contributors to fibroblast activation and myocardial fibrosis during physiological cardiac aging. However, their causal roles in vivo remain to be established by targeted genetic or pharmacologic perturbation.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied Physiological cardiac aging and myocardial fibrosis (n=20). Physiological aging (and in vitro recombinant HB-EGF or PDGF-AA stimulation) vs. Young hearts (8-10 weeks in mice; <45 years in humans) or vehicle control was evaluated on Age-associated cardiac macrophage transcriptional remodeling (TLF+CD209hi resident macrophage state) and myocardial fibrosis. Physiological cardiac aging enriched a profibrotic TLF+CD209hi resident macrophage state that promotes fibroblast activation via HB-EGF/AREG-EGFR and IL-10-associated PDGF-A/PDGFRa signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: